Literature DB >> 9532551

Disease severity, physical limitations and depression in HIV-infected men.

K W Griffin1, J G Rabkin, R H Remien, J B Williams.   

Abstract

Previous research has failed to identify a consistent relationship between HIV disease severity and depression. However, HIV/AIDS can lead to substantial physical limitations in those with advanced disease, which may influence mood. This study examined the extent to which HIV disease severity and physical limitations were associated with depressive symptoms in 49 HIV-infected men at the final stages of a 5-year prospective study. No differences were found in depression or quality of life among men who were asymptomatic, symptomatic, or diagnosed with AIDS. Forty-three percent of subjects reported substantial physical limitations, which were associated with higher depression scores and poorer quality of life. Degree of physical limitation predicted depression concurrently as well as depression 6 months later, after controlling for disease stage, physical symptoms, and CD4 cell counts. Findings suggest that physical limitations are more important than laboratory markers of disease progression in understanding psychological adjustment to illness in HIV-infected men.

Entities:  

Mesh:

Year:  1998        PMID: 9532551     DOI: 10.1016/s0022-3999(97)00205-5

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  10 in total

Review 1.  Affective disorders in patients with HIV infection: impact of antiretroviral therapy.

Authors:  Gabriele Arendt
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Quality of life among treatment seeking methamphetamine-dependent individuals.

Authors:  Rachel Gonzales; Alfonso Ang; Deborah C Glik; Richard A Rawson; Stella Lee; Martin Y Iguchi
Journal:  Am J Addict       Date:  2011-05-31

3.  Sources of emotional distress associated with diarrhea among late middle-age and older HIV-infected adults.

Authors:  Karolynn Siegel; Eric W Schrimshaw; Courtney J Brown-Bradley; Helen-Maria Lekas
Journal:  J Pain Symptom Manage       Date:  2010-06-25       Impact factor: 3.612

Review 4.  Clinical management of psychiatric disorders in patients with HIV disease.

Authors:  Eugene W Farber; J Stephen McDaniel
Journal:  Psychiatr Q       Date:  2002

Review 5.  Caring for adolescents with HIV.

Authors:  Patricia DeLaMora; Nina Aledort; Joseph Stavola
Journal:  Curr HIV/AIDS Rep       Date:  2006-07       Impact factor: 5.071

6.  Clinical importance of HIV and depressive symptoms among veterans with HIV infection.

Authors:  Amy M Kilbourne; Amy C Justice; Bruce L Rollman; Kathleen A McGinnis; Linda Rabeneck; Sharon Weissman; Susan Smola; Richard Schultz; Jeff Whittle; Maria Rodriguez-Barradas
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

7.  User acceptance of HIV TIDES--Tailored Interventions for Management of Depressive Symptoms in persons living with HIV/AIDS.

Authors:  Tsai-Ya Lai; Elaine L Larson; Maxine L Rockoff; Suzanne Bakken
Journal:  J Am Med Inform Assoc       Date:  2007-12-20       Impact factor: 4.497

Review 8.  Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in Human immunodeficiency virus disease.

Authors:  Dean G Cruess; Steven D Douglas; John M Petitto; Jane Leserman; Thomas Ten Have; David Gettes; Benoit Dubé; Dwight L Evans
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

9.  Health related quality of life among persons with HIV after the use of protease inhibitors.

Authors:  S Low-Beer; K Chan; E Wood; B Yip; J S Montaner; M V O'Shaughnessy; R S Hogg
Journal:  Qual Life Res       Date:  2000       Impact factor: 3.440

10.  Effect of COVID-19 stress on physical function performance and socioenvironmental factors of people with disabilities in Korea.

Authors:  Jae-Hak Kim; Hyun-Sill Rhee
Journal:  Int J Rehabil Res       Date:  2022-03-01       Impact factor: 1.479

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.